These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25723457)

  • 1. Exploration of N-arylpiperazine Binding Sites of D2 Dopaminergic Receptor.
    Soskic V; Sukalovic V; Kostic-Rajacic S
    Mini Rev Med Chem; 2015; 15(12):988-1001. PubMed ID: 25723457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of key receptor-ligand interactions of dopaminergic arylpiperazines and the dopamine D2 receptor homology model.
    Sukalovic V; Soskic V; Sencanski M; Andric D; Kostic-Rajacic S
    J Mol Model; 2013 Apr; 19(4):1751-62. PubMed ID: 23300056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, Biological, and Computational Evaluation of Substituted 1-(2-Methoxyphenyl)-4-(1-phenethylpiperidin-4-yl)piperazines and 1-(2-Methoxyphenyl)-4-[(1-phenethylpiperidin-4-yl)methyl]piperazines as Dopaminergic Ligands.
    Penjišević JZ; Šukalović VV; Andrić DB; Roglić GM; Šoškić V; Kostić-Rajačić SV
    Arch Pharm (Weinheim); 2016 Aug; 349(8):614-26. PubMed ID: 27335270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling of the D2 dopamine receptor arylpiperazine binding site for 1-[2-[5-(1H-benzimidazole-2-thione)]ethyl]-4-arylpiperazines.
    Sukalović V; Zlatović M; Andrić D; Roglić G; Kostić-Rajaccić S; Soskić V
    Arch Pharm (Weinheim); 2004 Sep; 337(9):502-12. PubMed ID: 15362123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of arylpiperazines with the dopamine receptor D2 binding site.
    Sukalović V; Zlatović M; Andrić D; Roglić G; Kostić-Rajacić S; Soskić V
    Arzneimittelforschung; 2005; 55(3):145-52. PubMed ID: 15819386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of the halogen bonding on D
    Partyka A; Kurczab R; Canale V; Satała G; Marciniec K; Pasierb A; Jastrzębska-Więsek M; Pawłowski M; Wesołowska A; Bojarski AJ; Zajdel P
    Bioorg Med Chem; 2017 Jul; 25(14):3638-3648. PubMed ID: 28529043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single glycine in extracellular loop 1 is the critical determinant for pharmacological specificity of dopamine D2 and D3 receptors.
    Michino M; Donthamsetti P; Beuming T; Banala A; Duan L; Roux T; Han Y; Trinquet E; Newman AH; Javitch JA; Shi L
    Mol Pharmacol; 2013 Dec; 84(6):854-64. PubMed ID: 24061855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A QM protein-ligand investigation of antipsychotic drugs with the dopamine D2 Receptor (D2R).
    Ekhteiari Salmas R; Serhat Is Y; Durdagi S; Stein M; Yurtsever M
    J Biomol Struct Dyn; 2018 Aug; 36(10):2668-2677. PubMed ID: 28805144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D(2)) and serotonin (5-HT(1A)) receptors.
    Penjisević J; Sukalović V; Andrić D; Kostić-Rajacić S; Soskić V; Roglić G
    Arch Pharm (Weinheim); 2007 Sep; 340(9):456-65. PubMed ID: 17763374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction of a new complex imide system into the structure of LCAPs. The synthesis and a 5-HT1A, 5-HT2A and D2 receptor binding study.
    Kossakowski J; Raszkiewicz A; Bugno R; Bojarski AJ
    Pol J Pharmacol; 2004; 56(6):843-8. PubMed ID: 15662099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling of the dopamine D2 and serotonin 5-HT1A receptor binding modes of the enantiomers of 5-OMe-BPAT.
    Homan EJ; Wikström HV; Grol CJ
    Bioorg Med Chem; 1999 Sep; 7(9):1805-20. PubMed ID: 10530928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D2, D3, and D4 selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding.
    Ehrlich K; Götz A; Bollinger S; Tschammer N; Bettinetti L; Härterich S; Hübner H; Lanig H; Gmeiner P
    J Med Chem; 2009 Aug; 52(15):4923-35. PubMed ID: 19606869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?
    Carli M; Kolachalam S; Aringhieri S; Rossi M; Giovannini L; Maggio R; Scarselli M
    Curr Neuropharmacol; 2018 Jan; 16(2):222-230. PubMed ID: 28521704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel series of hybrid compounds derived by combining 2-aminotetralin and piperazine fragments: binding activity at D2 and D3 receptors.
    Dutta AK; Fei XS; Reith ME
    Bioorg Med Chem Lett; 2002 Feb; 12(4):619-22. PubMed ID: 11844685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dopamine D2 receptor dimer and its interaction with homobivalent antagonists: homology modeling, docking and molecular dynamics.
    Kaczor AA; Jörg M; Capuano B
    J Mol Model; 2016 Sep; 22(9):203. PubMed ID: 27491852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of structurally constrained hybrid analogues containing ropinirole moiety as a novel class of potent and selective dopamine D3 receptor ligands.
    Zhou B; Hong KH; Ji M; Cai J
    Chem Biol Drug Des; 2018 Sep; 92(3):1597-1609. PubMed ID: 29710404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis and Pharmacological Evaluation of Novel Conformationally Restricted
    da Silva Cunha TT; Silva RR; Rodrigues DA; de Sena Murteira Pinheiro P; Kronenberger T; Sant'Anna CMR; Noël F; Fraga CAM
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new arylpiperazine antipsychotic with high D2/D3/5-HT1A/alpha 1A-adrenergic affinity and a low potential for extrapyramidal effects.
    Reitz AB; Bennett DJ; Blum PS; Codd EE; Maryanoff CA; Ortegon ME; Renzi MJ; Scott MK; Shank RP; Vaught JL
    J Med Chem; 1994 Apr; 37(8):1060-2. PubMed ID: 7909336
    [No Abstract]   [Full Text] [Related]  

  • 19. 1,4-Disubstituted aromatic piperazines with high 5-HT2A/D2 selectivity: Quantitative structure-selectivity investigations, docking, synthesis and biological evaluation.
    Möller D; Salama I; Kling RC; Hübner H; Gmeiner P
    Bioorg Med Chem; 2015 Sep; 23(18):6195-209. PubMed ID: 26299826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of 7TM receptor-ligand complex models using ligand-biased, semi-empirical helix-bundle repacking in torsion space: application to the agonist interaction of the human dopamine D2 receptor.
    Malo M; Persson R; Svensson P; Luthman K; Brive L
    J Comput Aided Mol Des; 2013 Mar; 27(3):277-91. PubMed ID: 23553533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.